Beijing Key Laboratory of Clinical Epidemiology, School of Public Health.
Department of Neurology, Beijing Tiantan Hospital, and.
JCI Insight. 2020 Aug 20;5(16):136982. doi: 10.1172/jci.insight.136982.
BACKGROUNDMetabolically healthy obesity (MHO) and metabolically healthy overweight (MH-OW) have been suggested to be important and emerging phenotypes with an increased risk of cardiovascular disease (CVD). However, whether MHO and MH-OW are associated with all-cause mortality remains inconsistent.METHODSThe association of MHO and MH-OW and all-cause mortality was determined in a Chinese community-based prospective cohort study (the Kailuan study), including 93,272 adults at baseline. Data were analyzed from 2006 to 2017. Participants were categorized into 6 mutually exclusive groups, according to BMI and metabolic syndrome (MetS) status. The primary outcome was all-cause death, and accidental deaths were excluded.RESULTSDuring a median follow-up of 11.04 years (interquartile range, 10.74-11.22 years), 8977 deaths occurred. Compared with healthy participants with normal BMI (MH-NW), MH-OW participants had the lowest risk of all-cause mortality (multivariate-adjusted HR [aHR], 0.926; 95% CI, 0.861-0.997), whereas there was no increased or decreased risk for MHO (aHR, 1.009; 95% CI, 0.886-1.148). Stratified analyses and sensitivity analyses further validated that there was a nonsignificant association between MHO and all-cause mortality.CONCLUSIONSOverweight and obesity do not predict increased risk of all-cause mortality in metabolic healthy Chinese individuals.FUNDINGNational Natural Science Foundation of China (NSFC; 81673247, 81872682 and 81773527), the NSFC Joint Project, and the Australian National Health and Medical Research Council (NHMRC; NSFC 81561128020-NHMRC APP1112767).
代谢健康型肥胖(MHO)和代谢健康型超重(MH-OW)被认为是具有增加心血管疾病(CVD)风险的重要新兴表型。然而,MHO 和 MH-OW 是否与全因死亡率相关仍然不一致。
在中国社区为基础的前瞻性队列研究(开滦研究)中,对 93272 名成年人进行了 MHO 和 MH-OW 与全因死亡率的相关性研究。数据分析时间为 2006 年至 2017 年。根据 BMI 和代谢综合征(MetS)状况,参与者被分为 6 个互斥组。主要结局为全因死亡,排除意外死亡。
在中位随访 11.04 年(四分位间距,10.74-11.22 年)期间,发生了 8977 例死亡。与健康的 BMI 正常参与者(MH-NW)相比,MH-OW 参与者的全因死亡率风险最低(多变量调整 HR[aHR],0.926;95%CI,0.861-0.997),而 MHO 患者的全因死亡率风险无增加或降低(aHR,1.009;95%CI,0.886-1.148)。分层分析和敏感性分析进一步验证了 MHO 与全因死亡率之间无显著关联。
在代谢健康的中国人群中,超重和肥胖并不能预测全因死亡风险增加。
国家自然科学基金(NSFC;81673247、81872682 和 81773527)、NSFC 联合项目和澳大利亚国家健康与医学研究委员会(NHMRC;NSFC 81561128020-NHMRC APP1112767)。